Resona Asset Management Co. Ltd. Purchases 18,440 Shares of Zoetis Inc. $ZTS

Resona Asset Management Co. Ltd. increased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 4.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 420,469 shares of the company’s stock after buying an additional 18,440 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Zoetis were worth $61,358,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ZTS. Halbert Hargrove Global Advisors LLC raised its position in shares of Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after purchasing an additional 144 shares during the period. REAP Financial Group LLC increased its stake in Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 131 shares in the last quarter. NewSquare Capital LLC increased its stake in Zoetis by 69.1% during the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after purchasing an additional 85 shares in the last quarter. ORG Partners LLC raised its holdings in Zoetis by 56.8% during the 2nd quarter. ORG Partners LLC now owns 232 shares of the company’s stock worth $37,000 after buying an additional 84 shares during the period. Finally, Financial Consulate Inc. bought a new position in Zoetis in the third quarter valued at approximately $39,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ZTS has been the subject of several research reports. Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research report on Thursday, December 18th. Bank of America cut Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a report on Monday, December 15th. JPMorgan Chase & Co. cut their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. UBS Group reduced their price objective on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Finally, Stifel Nicolaus dropped their target price on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Zoetis has an average rating of “Hold” and an average target price of $152.91.

Zoetis Trading Down 0.3%

Zoetis stock opened at $124.04 on Friday. The company has a market cap of $54.66 billion, a price-to-earnings ratio of 20.88, a P/E/G ratio of 2.16 and a beta of 0.97. The firm has a 50-day moving average of $123.58 and a 200-day moving average of $138.43. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. Zoetis Inc. has a one year low of $115.25 and a one year high of $177.40.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same quarter in the previous year, the business earned $1.58 earnings per share. Zoetis’s quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio (DPR) is currently 35.69%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.